Association of clinical androgen excess with radial artery intima media thickness in women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 31, Issue 6, 2015, Pages 477-482

  Yilmaz, S A ^a   Kebapcilar, A ^a   Koplay, M ^a   Kerimoglu, O S ^a   Pekin, A T ^a   Gencoglu, B ^a   Dogan, N U ^b   Celik, C ^a  

^a SELCUK UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Androgen; Body mass index; Cardiovascular disease; Intima media thickness; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; INSULIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MODIFIED FERRIMAN GALLWEY SCORE; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RADIAL ARTERY INTIMA MEDIA THICKNESS; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; ECHOGRAPHY; RADIAL ARTERY; YOUNG ADULT;

ADULT; ANDROGENS; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; RADIAL ARTERY; YOUNG ADULT;

EID: 84938092042     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2015.1014783     Document Type: Article

References (38)

1. Carmina E, Lobo R. Polycystic ovary syndrome: arguably the most common endocrinopathy is associated with morbidity in women. J Clin Endocrinol Metab 1999;84:1897-9.
2. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG 2006;113:1148-59.
3. Orio Jr F, Palomba S, Spinelli L, et al. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 2004;89:3696-701.
4. Kelly CJ, Speirs A, Gould GW, et al. Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:742-6.
5. Wenner MM, Taylor HS, Stachenfeld N. ET-B receptor contribution to peripheral microvascular functions in women with polycystic ovary syndrome. J Physiol 2011;589:4671-9.
6. Tarkun I, Arslan BC, Cantürk Z, et al. Endothelialdysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation. J Clin Endocrinol Metab 2004;89:5592-6.
7. Beckman JA, Goldfine AB, Dunaif A, et al. Endothelial function varies according to insulin resistance disease type. Diabetes Care 2007;30:1226-32.
8. Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome and type 2 diabetes. Fertil Steril 2002;77:1095-105.
9. Luque-Ramirez M, Mendieta-Azcona C, Alvarez-Blasco F, et al. Androgen excess is associated with the increased carotid intimamedia thickness observed in young women with polycystic ovary syndrome (PCOS). Hum Reprod 2007;22:3197-203.
10. Ruengsakulrach P, Sinclair R, Komeda M, et al. Comparative histopathology of radial artery versus internal thoracic artery and risk factors for development of intimal hyperplasia and atherosclerosis. Circulation 1999;100:139-44.
11. Guleria AK, Syal SK, Kapoor A, et al. Cardiovascular disease risk in young Indian women with polycystic ovary syndrome. Gynecol Endocrinol 2014;30:26-9.
12. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-7.
13. Wild RA, Vesely S, Beebe L, et al. FerrimanGallwey self scoring. I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4112-14.
14. Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59:141-54.
15. Morley JE, Patrick P, Perry 3rd HM. Evaluation of assays available to measure free testosterone. Metabolism 2002;5:554-9.
16. Lemarie CA, Tharaux PL, Lehoux S. Extracellular matrix alterations in hypertensive vascular remodeling. J Mol Cell Cardiol 2010;48: 433-9.
17. Tschakovsky ME, Pyke KE. Counterpoint: Flow-mediated dilation does not reflect nitric oxide-mediated endothelial function. J Appl Physiol 2005;99:1235-8.
18. Dahlgren E, Janson PO, Johansson S, et al. Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective study of women. Acta Obstet Gynecol Scand 1992;71:599-604.
19. Mather KJ, Verma S, Corenblum B, Anderson TJ. Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2000;85: 1851-6.
20. Barcellos CR, Lage SH, Rocha MP, et al. Polycystic ovary syndrome and obesity do not affect vascular parameters related to early atherosclerosis in young women without glucose metabolism disturbances, arterial hypertension and severe abnormalities of lipid profile. Gynecol Endocrinol 2013;29:370-4.
21. Kravariti M, Naka KK, Kalantaridou SN, et al. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. Clin Endocrinol Metab 2005;90:5088-95.
22. Chowdhury UK. Histopathology and morphometry of radial artery conduits: basic study and clinical application. Ann Thorac Surg 2004;78:1614-21.
23. Liu P, Death A, Handelsman D. Androgens and cardiovascular disease. Endocr Rev 2003;24:313-40.
24. Pierpoint T, McKeigue PM, Isaacs AJ, et al. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 1998;51:581-6.
25. Wild S, Pierpoint T, McKeigue PM, et al. Cardiovascular disease in women with polycystic ovary syndrome at long term follow-up: a retrospective cohort study. Clin Endocrinol 2000;52:595-600.
26. Hillebrand U, Hausberg M, Lang D, et al. How steroid hormones act on the endothelium insights by atomic force microscopy. Pflugers Arch 2008;456:51-60.
27. Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insülin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989;38:1165-74.
28. Yilmaz M, Biri A, Bukan N, et al. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Gynecol Endocrinol 2005;20:258-63.
29. Welt CK, Carmina E. Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab 2013; 98:4629-38.
30. O'Connor A, Phelan N, Tun TK, et al. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. J Clin Endocrinol Metab 2010;95:1378-85.
31. Villa J, Pratley R. Adipose tissue dysfunction in polycystic ovary syndrome. Curr Diabetes Rep 2011;11:179-84.
32. Botella-Carretero M, Bengura JI, Villuendas A, et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92: 328-37.
33. Xu XF, De Pergola G, Bjorntorp P. Testosterone increases lipolysis and the number of b-adrenoceptors in male rat adipocytes. Endocrinology 1991;128:379-82.
34. Benson S, Arck PC, Tan S, et al. Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology 2009;34:727-35.
35. Sverrisdóttir YB, Mogren T, Kataoka J, et al. Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? Am J Physiol Endocrinol Metab 2008;294:E576-81.
36. Murri M, Luque-Ram?rez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 2013;19: 268-88.
37. Christakou C, Economou F, Livadas S, et al. Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander? Hormones 2011;10:292-7.
38. Christian RC, Dumesic DA, Behrenbeck T, et al. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:2562-8.